2013 American Transplant Congress
Measuring Kidney Patients' Motivation To Pursue Living Donor Kidney Transplant: Development of Stage of Change, Decisional Balance and Self-Efficacy Measures
University of Rhode Island, Kingston, RI; Washington University School of Medicine, St. Louis, MO
Educational interventions that increase patient motivation to pursue living donor kidney transplant (LDKT), positive attitudinal change, and self-efficacy have been shown to increase LDKT rates,…2013 American Transplant Congress
Pretransplant FGF23 Titer Predicts Hypercalcemia at 6month Post Transplant Recipients
Kidney Disease Center, Nagoya Daini Red Cross Hospital, Nagoya, Japan
(Background) Recently graft survival of kidney transplant recipients is longer than before,so it is important to manage arteriosclerosis including calcium(Ca)/phosphorus(P) metabolism.(Aim)We examined how effective preemptive…2013 American Transplant Congress
Learning Curve of ECMO in DCD (Better the Devil You Know?)
Saint Louis Hospital (Assistance Publique - Hôpitaux de Paris), Paris, France
Kidney transplantation from uncontrolled Donation after Cardiac Death (DCD) has been re-introduced into clinical practice in France since June 2006. In addition to being the…2013 American Transplant Congress
Non-Invasive Diagnostic Markers for Differentiation between BKV-Associated Nephropathy and Acute Rejection in Renal Transplant Patients
BKV-associated nephropathy (BKVAN) causing kidney graft impairment is often difficult to distinguish from acute rejection (AR). A misdiagnosis may be detrimental to the patient, because…2013 American Transplant Congress
Transplant Renal Arterial Inflow Stenosis Defined by Contrast Enhanced MR Angiography and MR Imaging in Early Period after Renal Transplantation: Predisposing Factors and Clinical Outcomes
PurposeOur objective was to evaluate the usefulness of three-dimensional contrast enhanced MR angiography (3D CE MRA) for assessment of renal artery anastomosis in the early…2013 American Transplant Congress
Combined Costimulatory and OX40L Blockade Significantly Prolongs Transplant Survival in Mice and Non-Human Primates
Emory Transplant Center, Atlanta, GA; Juntendo University, Tokyo, Japan; Roche USA, New York, NY
Belatacept is the first clinically approved transplant immunosuppressant based on costimulatory blockade (CoB). Kidney transplant recipients treated with belatacept had improved long-term renal function, albeit…2013 American Transplant Congress
Open-Label Study of Planned Transition from Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Demographics and Interim Safety Results
Purpose: Evaluate planned transition from tacrolimus (TAC) to sirolimus (SRL) vs continued TAC in renal allograft recipients.Methods: This open-label, randomized, multinational phase 4 study screened…2013 American Transplant Congress
Clinical Risk Stratification Predicts Ischemic Cardiovascular Complications after Kidney Transplantation with High Sensitivity and Specificity
The predictive value of noninvasive cardiac test remains unclear in the kidney transplant(KT) population. We evaluated the performance of noninvasive tests and clinical risk stratification…2013 American Transplant Congress
Complication Free Heterotopic Cardiac Xenograft Survival by Anti CD40 Antibody Mediated Co-Stimulation Blockade
Introduction: Despite achieving longest reported graft survival by us via anti CD154 mediated co stimulation blockade, many coagulation disorders were witnessed due to direct binding…2013 American Transplant Congress
Alemtuzumab Induction in HCV Seropositive Kidney Transplant Recipients
Transplant Division, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
Background: Alemtuzumab (AZ) is a humanized anti-CD52 monoclonal antibody used as an induction agent in organ transplantation. The potency of alemtuzumab, is a concern for…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 178
- Next Page »